- Country or region
- Canada
- Trade topics
- Dispute settlement
- Dispute settlement
- WTO - Case launched by the EU
Summary of the case
- Complaint by: EU
- Complaint against: Canada
- Third parties: Austria, Brazil, Colombia, Cuba, India, Israel, Japan, Poland, Switzerland, Thailand, United States
Canada allows for start of commercial manufacture of patented medicines 6 months before the expiry of the patent and the manufacturing of the product for the purpose of securing the approval of generic medicines ("regulatory exception")
Relevant WTO provision: TRIPS (27.1, 28, 30, 33)
Status
EC prevailed on stockpiling exception. Implementation period (6 Months) determined by arbitration, ends on 7 Oct. 2000.
- Consultations requested: 19 December 1997
- Panel requested: 11 November 1998
- Panel established: 01 February 1999
- Panel report circulated: 17 March 2003
- Panel/Appellate Body report adopted: 07 April 2000
- Implementation deadline: 07 October 2000